We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Pankreas Kanseri Tanılı Hastalarımızda Prognostik Faktörlerin İncelenmesi.
- Authors
Yolaçan, Ramazan; Yiğit, Ercan; Karabulut, Ümit; Üzel, Ali; Uçmak, Feyzullah; Kaya, Muhsin
- Abstract
Objective: Pancreatic cancer is a disease with very poor prognosis and its incidence is gradually increasing. There are more than one prognostic marker in this disease. The aim of this study was to determine the prognostic factors affecting the survival of patients diagnosed with pancreatic cancer in our clinic. Methods: The demographic and clinical characteristics, laboratory results, contrast-enhanced abdominal tomography findings and responses to treatments of 127 patients who were admitted to our clinic between January 2011 and June 2020 and were diagnosed with pancreatic cancer were retrospectively evaluated. Results: 85 (67%) of the patients were male and 42 (33%) were female, the mean age was 62.6 ± 12.5 (27-90) years, the mean survival time was 11.6 ± 1.3 months; The 1-year mean survival rate was 31% and the 5-year mean survival rate was 0.9%. There was no significant relationship between pancreatic cancer prognosis and gender, tumor size, tumor location, presence of DM, presence of pathological LAP, vascular invasion, chemotherapy, serum CA 19-9 and CA125 levels. Advanced age (p = 0.01), liver metastasis (P = 0.016) and high serum CEA level (p = 0.013) were found to be poor prognostic factors, and surgical resection (p = 0.039) was found to be a good prognostic factor. Conclusion: It may be beneficial to consider the factors affecting the prognosis of the disease during the treatment of pancreatic cancer.
- Publication
Dicle Medical Journal / Dicle Tip Dergisi, 2022, Vol 49, Issue 1, p159
- ISSN
1300-2945
- Publication type
Article
- DOI
10.5798/dicletip.1086337